Product
Tenofovir/Emtricitabine FDC
1 clinical trial
3 indications
Indication
InfectionIndication
HIVIndication
HIV InfectionsClinical trial
A Phase IIIb, Randomized, Open-label Study of the Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine Once Daily Compared to Atazanavir and Ritonavir Plus Tenofovir/Emtricitabine Once Daily in HIV-1 Infected Antiretroviral Therapy Naïve WomenStatus: Completed, Estimated PCD: 2015-09-22